Freimut H Schilling

Summary

Affiliation: Klinikum Stuttgart
Country: Germany

Publications

  1. ncbi request reprint Neuroblastoma screening at one year of age
    Freimut H Schilling
    Klinikum Stuttgart, Olgahospital, Child and Adolescent Health, Pediatrics 5, Stuttgart, Germany
    N Engl J Med 346:1047-53. 2002
  2. ncbi request reprint Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany
    Freimut H Schilling
    Klinikum Stuttgart, Olgahospital, Child and Adolescent Health, D 70176 Stuttgart, Germany
    Cancer Lett 197:19-28. 2003
  3. doi request reprint Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97
    Barbara Hero
    Children s Hospital, Department of Pediatric Oncology and Hematology, University of Cologne, Kerpener Str 62, 50924 Cologne, Germany
    J Clin Oncol 26:1504-10. 2008
  4. pmc Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma
    Rene G Feichtinger
    Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria
    BMC Cancer 10:149. 2010
  5. ncbi request reprint [Neuroblastoma Early Detection Model Project. Background and results]
    Freimut H Schilling
    Klinikum Stuttgart Olgahospital Klinik für Kinderheilkunde und Jugendmedizin Pädiatrie 5 Onkologie Hämatologie Immunologie Bismarckstrasse 8, 70176 Stuttgart
    Kinderkrankenschwester 21:295-6. 2002
  6. doi request reprint Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma
    Thorsten Simon
    Department of Pediatric Oncology and Hematology, Children s Hospital, University of Cologne, Cologne, Germany
    Dev Med Child Neurol 54:347-52. 2012
  7. ncbi request reprint Lead-time and overdiagnosis estimation in neuroblastoma screening
    Claudia Spix
    Johannes Gutenberg University, German Childhood Cancer Registry, Mainz, Germany
    Stat Med 22:2877-92. 2003
  8. ncbi request reprint Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
    Frank Berthold
    Children s Hospital and Centre for Molecular Medicine, University of Cologne, Cologne, Germany
    Lancet Oncol 6:649-58. 2005

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Neuroblastoma screening at one year of age
    Freimut H Schilling
    Klinikum Stuttgart, Olgahospital, Child and Adolescent Health, Pediatrics 5, Stuttgart, Germany
    N Engl J Med 346:1047-53. 2002
    ..Neuroblastoma is the second most common type of childhood tumor. It is not known whether screening for neuroblastoma at one year of age reduces the incidence of metastatic disease or mortality due to neuroblastoma...
  2. ncbi request reprint Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany
    Freimut H Schilling
    Klinikum Stuttgart, Olgahospital, Child and Adolescent Health, D 70176 Stuttgart, Germany
    Cancer Lett 197:19-28. 2003
    ..Comparison of the screened group and the control area revealed substantial over diagnosis in the screened participants. The present findings provide no support for mass screening for neuroblastoma at 1 year of age...
  3. doi request reprint Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97
    Barbara Hero
    Children s Hospital, Department of Pediatric Oncology and Hematology, University of Cologne, Kerpener Str 62, 50924 Cologne, Germany
    J Clin Oncol 26:1504-10. 2008
    ....
  4. pmc Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma
    Rene G Feichtinger
    Department of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria
    BMC Cancer 10:149. 2010
    ..Succinate dehydrogenase (SDH) has been associated with carcinogenesis in pheochromocytoma and paraganglioma. In the present study we investigated components of the oxidative phosphorylation system in human neuroblastoma tissue samples...
  5. ncbi request reprint [Neuroblastoma Early Detection Model Project. Background and results]
    Freimut H Schilling
    Klinikum Stuttgart Olgahospital Klinik für Kinderheilkunde und Jugendmedizin Pädiatrie 5 Onkologie Hämatologie Immunologie Bismarckstrasse 8, 70176 Stuttgart
    Kinderkrankenschwester 21:295-6. 2002
  6. doi request reprint Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma
    Thorsten Simon
    Department of Pediatric Oncology and Hematology, Children s Hospital, University of Cologne, Cologne, Germany
    Dev Med Child Neurol 54:347-52. 2012
    ..Prospective trials on neuroblastoma-induced myelopathy are lacking. Therefore, we retrospectively analysed patients in four national neuroblastoma trials...
  7. ncbi request reprint Lead-time and overdiagnosis estimation in neuroblastoma screening
    Claudia Spix
    Johannes Gutenberg University, German Childhood Cancer Registry, Mainz, Germany
    Stat Med 22:2877-92. 2003
    ..The number of cases who might benefit is much smaller than was expected before the study while the overdiagnosed group is much larger. The method is robust against the choices that have to be made in the estimation process...
  8. ncbi request reprint Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
    Frank Berthold
    Children s Hospital and Centre for Molecular Medicine, University of Cologne, Cologne, Germany
    Lancet Oncol 6:649-58. 2005
    ..We aimed to assess whether megatherapy with autologous stem-cell transplantation could increase event-free survival and overall survival compared with maintenance chemotherapy...